Ian joined Ardena in 2025 as US Managing Director. He has over 30 years of global experience across multiple functions in both the CDMO and Medical device industry. Ian spent 19 years of his career working at GE in Quality, Finance, Supply Chain, Technical services and Commercial operations. He then joined Catalent in 2013 where he was VP of Sales Operations and more recently GM for the Somerset site. He holds degree in Mechanical Engineering and an MBA from Northwestern University – Kellogg School of Management.
Arnout Everaert
Arnout Everaert is Head of Drug Product Europe at Ardena, where he leads the company’s drug product development and manufacturing strategy across its European operations. He is responsible for advancing Ardena’s integrated service offering, strengthening operational alignment between sites, and supporting the company’s continued growth as a leading CDMO.
Arnout holds a PhD in Pharmaceutical Sciences. He brings extensive experience in formulation development, CMC strategy, and GMP manufacturing, with a strong track record in guiding complex drug products from development through clinical supply. Since joining Ardena in 2017, he has held several senior leadership roles, most recently serving as Business Unit Director at the Ghent site.
As a member of the leadership team, Arnout focuses on driving strategic initiatives, fostering collaboration across functions and geographies, and ensuring Ardena continues to deliver high-quality, scientifically driven solutions to its clients.
Ariane De Ganck, PhD
Since 2019, Ariane has overseen Ardena’s drug product activities, spearheading successful integration and transformation at Ardena Pamplona and expanding the company’s capabilities to include sterile services.
With over a decade of senior management experience in CRO/CDMO sectors, Ariane excels in leading multidisciplinary teams and is dedicated to team development, fostering networks, and maintaining a customer-centric approach. Her leadership has also been instrumental in driving business development initiatives.
Prior to joining Ardena, Ariane made significant contributions to the growth of Biogazelle, a specialized CRO in RNA and DNA biomarker services.
Ariane holds a PhD in biomedical sciences, focusing on proteins and oncology
Ardena Pamplona
Welcome to Ardena Pamplona
Our Pamplona site specializes in oral solid drug development and manufacturing, with expertise in highly potent compounds up to OEB5 and spray-drying technology to enhance the bioavailability of poorly soluble drugs.
With a growing scientific and operations team of 110+, we focus on niche oncology treatments and orphan drugs — making a real difference for patients who are waiting.
Facility Details
Address
Calle Noáin, 1 31110 Noáin, Spain +34 948 214 023
Employees
100+ team members
Whistleblower Channel
Certifications
Services
Ardena Ghent
Welcome to Ardena Ghent
Our headquarters and a hub for drug product development and manufacturing, Ardena Ghent is home to 110+ employees. This site also houses our CMC Regulatory team, providing specialist expertise and tailored services to support customers from pre-clinical to clinical manufacturing.
With a focus on injectable and oral drugs — particularly those with low solubility challenges — our site in Ghent is a center of excellence for drug products, clinical logistics, and CMC regulatory services.
Facility Details
Address
Kleimoer 4 9030 Ghent, Belgium +32 9 267 65 00
Employees
110+
Certifications
Services